SME Central
Home / Moved to Main Board / Ajooni Biotech

Ajooni Biotech: IPO, Share Price and Results Since Listing

Ajooni Biotech moved from NSE Emerge to the NSE main board on 7 May 2021. For Q2 FY2027 it reported revenue of INR 65.37 crore (+105.98% on a year earlier) and a profit after tax of INR 0.51 crore.

Key Facts

Moved to
NSE main board on 7 May 2021
Symbol
AJOONI
Latest close
INR 3.07 on 16 November 2026

Results Filed With NSE

Standalone figures, INR crore. Change compares with the same period a year earlier.

PeriodRevenueChangeProfit after taxEPS (INR)Filed
Q2 FY202765.37+105.98%0.510.02main board13 November 2026
Q1 FY202763.49+103.06%0.430.01main board14 August 2026
Q4 FY202660.62+107.08%0.950.05main board28 May 2026
FY2026182.38+59.02%4.320.25main board28 May 2026
Q3 FY202658.75–1.650.10main board30 January 2026
Q2 FY202631.74–0.930.08main board13 November 2025
Q1 FY202631.27–0.780.02main board14 August 2025
Q4 FY202529.27–1.540.09main board26 May 2025
FY2025114.69–3.370.20main board26 May 2025

Promoter Holding

Promoter holding has moved from 51.64% on 30 June 2021 to 30.53% on 30 September 2026 (-21.11 percentage points).

As ofPromotersPublic
30 September 202630.53%69.47%
12 August 202630.53%69.47%
30 June 202626.89%73.11%
31 March 202626.89%73.11%
31 December 202526.89%73.11%
30 September 202526.89%73.11%
30 June 202526.89%73.11%
31 March 202526.89%73.11%
31 December 202426.89%73.11%
30 September 202426.89%73.11%
30 June 202426.89%73.11%
6 June 202426.89%73.11%
31 March 202426.44%73.56%
31 December 202326.44%73.56%
30 September 202327.46%72.53%
30 June 202330.28%69.72%
31 March 202336.39%63.60%
31 December 202236.39%63.61%
24 December 202236.39%63.61%
30 September 202232.41%67.59%
30 June 202252.62%47.38%
31 March 202252.62%47.38%
31 December 202152.62%47.38%
30 September 202152.62%47.39%
30 June 202151.64%48.36%

Sources: NSE filings (results XBRL, shareholding pattern, board meetings), NSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.